{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [
    [
      "FT-ICR MS",
      "intrasurgical diagnosis",
      "metabolites",
      "molecular pathology"
    ]
  ],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "25246570",
  "DateCompleted": {
    "Year": "2015",
    "Month": "04",
    "Day": "24"
  },
  "DateRevised": {
    "Year": "2021",
    "Month": "10",
    "Day": "21"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2014",
        "Month": "09",
        "Day": "22"
      }
    ],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "10.1073/pnas.1408129111"
    ],
    "Journal": {
      "ISSN": "1091-6490",
      "JournalIssue": {
        "Volume": "111",
        "Issue": "42",
        "PubDate": {
          "Year": "2014",
          "Month": "Oct",
          "Day": "21"
        }
      },
      "Title": "Proceedings of the National Academy of Sciences of the United States of America",
      "ISOAbbreviation": "Proc Natl Acad Sci U S A"
    },
    "ArticleTitle": "Application of desorption electrospray ionization mass spectrometry imaging in breast cancer margin analysis.",
    "Pagination": {
      "StartPage": "15184",
      "EndPage": "15189",
      "MedlinePgn": "15184-9"
    },
    "Abstract": {
      "AbstractText": [
        "Distinguishing tumor from normal glandular breast tissue is an important step in breast-conserving surgery. Because this distinction can be challenging in the operative setting, up to 40% of patients require an additional operation when traditional approaches are used. Here, we present a proof-of-concept study to determine the feasibility of using desorption electrospray ionization mass spectrometry imaging (DESI-MSI) for identifying and differentiating tumor from normal breast tissue. We show that tumor margins can be identified using the spatial distributions and varying intensities of different lipids. Several fatty acids, including oleic acid, were more abundant in the cancerous tissue than in normal tissues. The cancer margins delineated by the molecular images from DESI-MSI were consistent with those margins obtained from histological staining. Our findings prove the feasibility of classifying cancerous and normal breast tissues using ambient ionization MSI. The results suggest that an MS-based method could be developed for the rapid intraoperative detection of residual cancer tissue during breast-conserving surgery."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Departments of Neurosurgery."
          }
        ],
        "LastName": "Calligaris",
        "ForeName": "David",
        "Initials": "D"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Departments of Neurosurgery, Radiology, Surgery, and."
          }
        ],
        "LastName": "Caragacianu",
        "ForeName": "Diana",
        "Initials": "D"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Departments of Neurosurgery."
          }
        ],
        "LastName": "Liu",
        "ForeName": "Xiaohui",
        "Initials": "X"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Departments of Neurosurgery."
          }
        ],
        "LastName": "Norton",
        "ForeName": "Isaiah",
        "Initials": "I"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Bruker Daltonics, Billerica, MA 01821; and."
          }
        ],
        "LastName": "Thompson",
        "ForeName": "Christopher J",
        "Initials": "CJ"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02215."
          }
        ],
        "LastName": "Richardson",
        "ForeName": "Andrea L",
        "Initials": "AL"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Surgery, and."
          }
        ],
        "LastName": "Golshan",
        "ForeName": "Mehra",
        "Initials": "M"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Bruker Daltonics, Billerica, MA 01821; and."
          }
        ],
        "LastName": "Easterling",
        "ForeName": "Michael L",
        "Initials": "ML"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02215."
          }
        ],
        "LastName": "Santagata",
        "ForeName": "Sandro",
        "Initials": "S"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115;"
          }
        ],
        "LastName": "Dillon",
        "ForeName": "Deborah A",
        "Initials": "DA"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Radiology."
          }
        ],
        "LastName": "Jolesz",
        "ForeName": "Ferenc A",
        "Initials": "FA"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Departments of Neurosurgery, Radiology, Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02215 nathalie_agar@dfci.harvard.edu."
          }
        ],
        "LastName": "Agar",
        "ForeName": "Nathalie Y R",
        "Initials": "NY"
      }
    ],
    "GrantList": [
      {
        "GrantID": "DP2 OD007383",
        "Acronym": "OD",
        "Agency": "NIH HHS",
        "Country": "United States"
      },
      {
        "GrantID": "P41 RR019703",
        "Acronym": "RR",
        "Agency": "NCRR NIH HHS",
        "Country": "United States"
      },
      {
        "GrantID": "P41RR019703",
        "Acronym": "RR",
        "Agency": "NCRR NIH HHS",
        "Country": "United States"
      },
      {
        "GrantID": "1DP2OD007383-01",
        "Acronym": "OD",
        "Agency": "NIH HHS",
        "Country": "United States"
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Research Support, N.I.H., Extramural",
      "Research Support, Non-U.S. Gov't",
      "Research Support, U.S. Gov't, Non-P.H.S."
    ]
  },
  "MedlineJournalInfo": {
    "Country": "United States",
    "MedlineTA": "Proc Natl Acad Sci U S A",
    "NlmUniqueID": "7505876",
    "ISSNLinking": "0027-8424"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Biomarkers, Tumor"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Fatty Acids"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Lipids"
    },
    {
      "RegistryNumber": "2UMI9U37CP",
      "NameOfSubstance": "Oleic Acid"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "Adult"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Aged"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Biomarkers, Tumor"
    },
    {
      "QualifierName": [
        "metabolism",
        "pathology"
      ],
      "DescriptorName": "Breast Neoplasms"
    },
    {
      "QualifierName": [
        "metabolism",
        "pathology"
      ],
      "DescriptorName": "Breast Neoplasms, Male"
    },
    {
      "QualifierName": [
        "chemistry"
      ],
      "DescriptorName": "Fatty Acids"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Female"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [
        "chemistry"
      ],
      "DescriptorName": "Lipids"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Male"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Mastectomy"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Middle Aged"
    },
    {
      "QualifierName": [
        "metabolism",
        "pathology"
      ],
      "DescriptorName": "Neoplasms"
    },
    {
      "QualifierName": [
        "chemistry"
      ],
      "DescriptorName": "Oleic Acid"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Recurrence"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Spectrometry, Mass, Electrospray Ionization"
    }
  ],
  "CoiStatement": "Conflict of interest statement: In compliance with Harvard Medical School and Partners Healthcare guidelines on potential conflict of interest, we disclose that S.S. and N.Y.R.A. are scientific advisors to BayesianDx."
}